Not applicableStudy completedNCT00776958What this trial is testingLynne Cohen Consortium Project: Multi-Center Database/RegistryWho this might be right forOvarian CancerBreast Cancer M.D. Anderson Cancer Center 176
Not applicableActive Not RecruitingNCT04585074What this trial is testingProspective Study of MAstectomy With Reconstruction Including Robot Endoscopic SurgeryWho this might be right forBreast NeoplasmsGermline BRCA1 Gene MutationGermline BRCA2 Gene Mutation+2 more Severance Hospital 2,000
Not applicableStudy completedNCT02039388What this trial is testingLavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial CarcinomaWho this might be right forOvarian Epithelial CancerCarcinoma in SituOvarian Cancer Medical University of Vienna 701
Not applicableWithdrawnNCT00580021What this trial is testingClinical Outcomes in Hereditary CancerWho this might be right forBreast CancerPancreatic Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT04556292What this trial is testingA Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer PatientsWho this might be right forBreast Cancer MetastaticBRCA 1 Gene MutationBRCA 2 Gene Mutation Jiangxi Qingfeng Pharmaceutical Co. Ltd. 78
Testing effectiveness (Phase 2)Ended earlyNCT03442556What this trial is testingDocetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair DeficiencyWho this might be right forATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more University of Washington 18
Testing effectiveness (Phase 2)Study completedNCT03845296What this trial is testingRucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationLoss of Heterozygosity+8 more SWOG Cancer Research Network 64
Testing effectiveness (Phase 2)Study completedNCT01009788What this trial is testingABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast CancerWho this might be right forBreast CancerMetastatic Breast CancerBRCA1 Gene Mutation+1 more Steven J Isakoff, MD, PhD 63
Not applicableStudy completedNCT03889171What this trial is testingComparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics TestsWho this might be right forCancerColorectal CancerBreast Cancer+1 more University Hospital, Montpellier 200
Not applicableLooking for participantsNCT07436312What this trial is testingImpact of Consumption of Ultra-processed Foods in Individuals at High Risk of CancerWho this might be right forBreast CancerPancreas CancerColon Cancer+3 more Gustave Roussy, Cancer Campus, Grand Paris 170
Testing effectiveness (Phase 2)Study completedNCT00082641What this trial is testingNeoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast CancerWho this might be right forBreast Cancer University of Nebraska 24
Very early researchActive Not RecruitingNCT03943173What this trial is testingOlaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before SurgeryWho this might be right forBRCA-Mutated Ovarian CarcinomaBRCA1 Gene MutationBRCA2 Gene Mutation+28 more M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT07292246What this trial is testingA Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)Who this might be right forBreast CancerBRCA 1 Gene MutationBRCA 2 Gene Mutation+5 more Vasileios Kalles 15
Early research (Phase 1)Study completedNCT00516373What this trial is testingAssess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)Who this might be right forOvarian NeoplasmsBRCA1 ProteinBRCA2 Protein AstraZeneca 98
Not applicableUnknownNCT01907438What this trial is testingTransformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast CellsWho this might be right forBRCA1 Gene MutationBRCA2 Gene Mutation Hadassah Medical Organization 30
Large-scale testing (Phase 3)Study completedNCT02000622What this trial is testingAssessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.Who this might be right forBreast Cancer MetastaticBRCA 1 Gene MutationBRCA 2 Gene Mutation AstraZeneca 302
Testing effectiveness (Phase 2)Study completedNCT00753545What this trial is testingAssessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian CancerWho this might be right forOvarian Cancer AstraZeneca 265
Testing effectiveness (Phase 2)UnknownNCT01772979What this trial is testingStudy With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian CancerWho this might be right forBRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Catholic University of the Sacred Heart 100
Early research (Phase 1)Study completedNCT01339650What this trial is testingStudy of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian TubePrimary Peritoneal CancerSolid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian AbbVie (prior sponsor, Abbott) 93
Testing effectiveness (Phase 2)Looking for participantsNCT05806515What this trial is testingCarboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationWho this might be right forProstate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8 SWOG Cancer Research Network 44